What changed
$CNM — WATCHLIST 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ1 FY2027 (ends May) | reported Jun 10 | Rev $1.9B | EPS $0.70 vs $0.68 🟢 | Margin 9.3%
💡 Market expects low growth, and the slight EPS beat does not alter the narrative. Consensus likely already discounts a cyclical recovery that may not materialize. No variant view.
🏢 Business Quality: 4/10
📊 Valuation: rich — P/E cheap (17.6 vs sector 21) but EV/EBITDA extremely elevated (51x) and FCF yield near zero (0.7%). Range: bear $39, base $49, bull $59.
🔮 Catalyst: next earnings release
⚖️ Watchlist only: the EPS beat is noise; high leverage, near-zero FCF yield, and a 1:1 reward/risk offer no edge.